| |
 |
Vector Research - Global
Technologies.
|
VRG’s goal is to provide unique products in the fields of biotechnology
and medical devices (e.g. microbiological testing), genomics,
pharmaceuticals (e.g. topical enzyme complexes, enzymatic debriding
ointments and dressings, antiviral products,
site-specific covalent incorporation of radioactive label in antitumor
antibodies for the treatment of cancers), protein synthesis (protease for
fusion expressing systems), and services such as contracted
bio-remediation (remediation of contaminated water, soil and air /
environmental protection).
We
anticipate submitting applications for FDA approval during the 1st quarter of 2002 regarding
microbiological testing and topical medications. VRG anticipates offering
its first products immediately after FDA approvals consisting of anthrax
test kits and topical skin products for the treatment of acne, pressure
ulcers and folliculitis.
Anthrax test kit:
Provides a sensitive, specific, simple, quick (six minute), cost effective
test for the presence of anthrax bacteria. Utilizes lateral-flow
immunochromatography (LFIC). This product is for environmental testing
only and not for use with humans nor human specimens.
|
|
